Review Proposal – June 2010

Review of NICE Technology Appraisal Guidance no. 85; immunosuppressive therapy for renal transplantation in adults

Proposal to plan guidance into the appraisal work programme

 

As you may be aware the planned date for review of the above guidance was March, 2010.

This is the date when the Institute decides whether sufficient new evidence has emerged for the Appraisal Committee to be asked to undertake an update of the existing guidance.

The Institute has carried out a search for information relevant to this appraisal, and believes that it is appropriate for the guidance to be updated. The original guidance will be reviewed with the inclusion of the following technologies:

• everolimus
• belatacept
• rabbit antithymocyte globulin
• mycophenolate sodium
• tacrolimus (new modified-release formulation)

In order to be completely confident that this is appropriate, we are asking consultees and commentators with an interest in this topic, to inform us of any evidence which would suggest that an earlier review would be beneficial. We would particularly like to be made aware of timelines around on-going research, etc. which might affect the scheduling of this review should we go ahead with the proposal following this consultation.

June 2010

• Appendix A: matrix of stakeholders
• Appendix B: proposal paper presented to the Institute’s Guidance Executive